269. Pyogenic arthritis Clinical trials / Disease details


Clinical trials : 24 Drugs : 30 - (DrugBank : 12) / Drug target genes : 15 - Drug target pathways : 105

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04895566
(ClinicalTrials.gov)
May 24, 202117/5/2021Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent PyodermaPhase 0/1 Topical Application of the Monoclonal Antibody (Mab) sB24M in Patients With Severe PyodermaPyoderma;Pyoderma Gangrenosum;Pyoderma Vegetans;Pyoderma Gangrenosum Surrounding Surgical StomaBiological: Monoclonal antibody (Mab) sB24MSWISS BIOPHARMA MED GmbHNULLActive, not recruiting21 Years80 YearsAll10Early Phase 1Belarus;Latvia